Open access peer-reviewed chapter

Medicinal Properties of Phytochemicals and Their Production

Written By

Aanchal Bansal and Chinmayee Priyadarsini

Submitted: 30 May 2021 Reviewed: 14 June 2021 Published: 15 July 2021

DOI: 10.5772/intechopen.98888

From the Edited Volume

Natural Drugs from Plants

Edited by Hany A. El-Shemy

Chapter metrics overview

1,538 Chapter Downloads

View Full Metrics


Phytochemicals are produced by plants as a defence mechanism against pathogens. They are used to treat various metabolic, immunological and neurological disorders in humans in various parts of the world as a part of traditional medicine. The use of indigenous plants in commercial medicine is rising with increasing population. The antimicrobial properties of plant extracts led to increased demands. Plant tissue culture on the other hand, has proved to be a reliable alternative for the production of bioactive compounds from plants. Artificial plant culture can enhance the production of phytochemicals in medicinal plants. This review focuses on the medicinal properties of phytochemicals and their in-vitro production.


  • plants
  • health
  • phytochemicals
  • antimicrobial
  • metabolic
  • in-vitro

1. Introduction

In the modern era of medicine, plants are still used as traditional mode of healthcare against certain disorders [1]. Plants can protect themselves from pathogenic microorganisms, harmful insects and adverse environmental changes by producing certain chemicals or secondary metabolites which are non-nutritive [2], but useful in defence mechanism. These are known as Phytochemicals, and somewhat essential oils. It can not only protect plants, but also humans and animals against certain diseases which are either caused by microorganisms or toxins produced by the microorganism. This is due to its antimicrobial property [3]. In future, phytochemicals can be used as chemo-preventive agents [4]. Till date, a number of phytochemicals have been discovered based on difference in chemical structure and have been classified as major groups [5]. The major groups of phytochemicals are phytosterols, flavonoids, terpenoids, saponins, alkaloids, carotenoids, aromatic acid, organic acid, essential oils and protease inhibitors [6]. Due to certain properties like antimicrobial, anti-inflammatory, anthelmintic, anticarcinogenic, antigenotoxic, antiproliferative, antimutagenic and antioxidative, the metabolites can provide direct or indirect defensive mechanism against pathogens or harmful ailments [7] (Figure 1).

Figure 1.

Medicinal properties of phytochemicals.


2. Antimicrobial properties

2.1 Antibacterial

Helicobacter pylori colonises on the epithelial layer of gastric mucosa and cause peptic ulcers and adenocarcinoma of distal stomach. Successful treatment of H. pylori infection has been observed by combination treatment of a proton pump inhibitor with two antibiotics. The bacterium has evolved and become resistant to the antibiotics [8]. Thus, there is a need to find alternative to current antibiotics. Recently, certain plant extracts and substances have been isolated such as alkaloids, polysaccharides and flavonoids which have shown effective cure against H. pylori infection. Daucus carota (carrot) seed oil has been found most effective against H. pylori in vitro [9].

Mycoplasmas are microorganisms lacking a rigid cell wall. Generally, their physiological habitats are plants and animals, but they can cause infection to humans. Furneri et al. [10] in his recent experiment has exposed 25 clinically isolated strains to TTO (Tea Tree Oil). They used broth microdilution assay to determine the MIC values.

Diseases like pneumonia, sinusitis, bronchitis, tonsillitis and viral infections such as common cold develop due to bacterial infection in the respiratory tract and the microorganisms commonly related to this infection are Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis. Traditionally, essential oils have been in use for the treatment of respiratory tract infections. They are either inhaled by steam, administered orally or applied by rubbing on the chest due to its secretolytic and secretomotoric properties. Except Streptococcus pyogenes, all other respiratory tract infecting microorganisms are susceptible to essential oils extracted (in vitro) from lemon grass (Cymbopogon citratus), lemon balm (Melissa officinalis), cinnamon bark (Cinnamomum verum) and thyme (Thymus vulgaris). Essential oils from peppermint (Mentha piperita) and eucalyptus (Eucalyptus globulus) can also be used but it shows low activity. Most of the active essential oils showed antibacterial effect at a concentration ranging from 1.56 to 6.25 μg/ml in its gaseous phase [11]. Thus, these can used to treat the infection by inhalation. Tea tree oil (TTO) is used worldwide in sectors including skin care cosmetics, nursing, and for successful treatment of bacterial and fungal infections [12]. It showed high antibacterial activity against S. aureus both in vitro and in vivo [13].

2.2 Antiviral

Natural products in the form of pure compound or as a plant extract can be used as antiviral drugs due to unmatched availability of chemicals [14]. Besides certain chemicals, natural products can be used as novel therapeutic agents for treatment of various diseases including viral infections. Viral infections have resisted prophylaxis as compared to than other microorganisms which is of major concern worldwide. Currently, very few antiviral medicines are available and there is a need to find new substances showing both extracellular and intracellular antiviral properties. The parameters commonly taken into consideration during evaluation of antiviral property of a substance (may be natural or synthetic) are reduction in the virus yield, inhibition of cytopathic effects, reduction or inhibition of plaque formation, and other viral functions in selected host cell cultures.

Scientific evidences have shown human viral infections can be treated by plant-derived phyto-antiviral agents produced in vitro [8]. To investigate the antiviral activity of essential oils, they were tested against enveloped and non-enveloped RNA and DNA viruses. Most of the tests were performed against the former such as herpes simplex virus type 1 and type 2 (DNA viruses), dengue virus type 2 (RNA virus), influenza virus (RNA virus) and Junin virus (RNA virus). Only a few essential oils such as oregano (Origanum vulgare) oil and clove (Syzygium aromaticum) oil were tested against non-enveloped viruses such as adenovirus type 3 (DNA virus), poliovirus (RNA virus), and coxsackievirus B1 (RNA virus).

Herpes simplex virus type 1 (HSV-1) causes infections such as herpetic encephalitis, herpetic keratitis, mucocutaneous herpes infections and neonatal herpes. For the treatment of this infection Acyclovir is used which is a nucleoside analogue and a selective anti-herpetic agent. It inhibits the replication of viral DNA through viral thymidine kinase, inhibition its synthesis. But, resistant HSV strains against this drug have been isolate from immunosuppressed hosts, such as patients suffering from AIDs and malignancy, and patients undergoing bone marrow or organ transplants [15]. Recent researches have demonstrated the antiviral effect of certain essential oils against these resistant HSV strains [16].

Currently, Coronavirus disease of 2019 (COVID-19) is a global threat. Unfortunately, very limited drugs have shown effectiveness against SARs-CoV-2 virus and its inflammatory complications [17]. Combinations of certain medicines are used such as antiviral (remdesivir), dexamethasone, antimalarials (chloroquine/hydroxychloroquine), and IL-6 receptor blocking monoclonal antibodies (tocilizumab), for the treatment of the disease. Studies have proposed essential oils showing activity against the SARs-CoV-2 virus due to various properties such as antiviral, anti-inflammatory, broncho dilatory, immuno-modulatory. Since essential oils have lipophilic nature, it can easily penetrate the viral membrane causing its membrane disruption. Essential oils also contain multiple active phytochemicals which can act on multiple viral replication stages inducing positive effect on the host’s respiratory system including lysis of mucus and bronchodilation. Thus, a combination of chemo-herbal essential oils could be feasible and effective to combat the pandemic virus.

2.3 Antifungal

Phytochemicals are antifungal as they can induce cytotoxicity in fungi by disrupting the membrane permeability of cell; inhibiting enzymes involved in mitochondria, cytoplasm and cell wall synthesis; and altering the cell compartment, and redox and osmotic balance. Some herbal plants showed antifungal and anti-mycotoxigenic activities along with antioxidant activity against phytotoxic fungal strains such as Fusarium verticillioides, spergillus. Ochraceous and Aspergillus flavus. The results reported, use of selected medicinal plants as bio fungicides may prevent food spoilage due to oxidation [18]. Study by Abdel-Fattah et al. reported, the extract of wild stevia shows potential antifungal, anti-mycotoxigenic and antioxidant activities against Aspergillus flavus, Aspergillus ochraceus, Aspergillus niger, and Fusarium moniliforme [19]. Besides, essential oils have the ability to regulate the growth of mycotoxigenic fungi including Aspergillus favus, Aspergillus oryzae, Aspergillus niger, Alternaria alternata, Fusarium moniliforme, Fusarium graminearum, Penicillium citrinum and Penicillum viridicatum and many more to list.

Curcumin and ellagic acid are some phytochemicals used in feed and food supplements [20]. These prevent the Aflatoxin B1 (AFB1) metabolism and increases glutathione-S-transferase activity which are involved in xenobiotic detoxification.

Red fruits and vegetables such as papaya and tomato have a compound named Lycopene. This compound has shown defensive mechanism against reproductive, hormonal damage and ZEN oxidation in mice [21]. It also prevents oxidative stress induced by T-2 toxin and maintains GSH cellular level in vivo. The antibacterial, antiviral and antifungal properties have been described in Table 1.

EffectMicrobial speciesPlant extractReferences
AntibacterialHelicobacter pyloriDaucus carota (carrot) seed oilBergonzelli et al. [9]
MycoplasmasTea tree oilFurneri et al. [10]
Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalisEssential oilsInouye et al. [1]
AntiviralHerpes simplex virus type 1 (HSV-1)Essential oilsSchnitzler et al. [16]
Adenovirus, poliovirusOregano oil, clove oilReichling et al. [8]
CoronavirusEssential oilsAsif et al. [17]
AntifungalAspergillus, FusariumWild stevia extract
Curcumin and ellagic acid
Abdel-Fattah et al. [19]
Gowda et al. [20]
Zearalenone producing speciesLycopeneAydin et al. [21]

Table 1.

Antimicrobial properties of phytochemicals.


3. Metabolic disorders

3.1 Obesity

Obesity occurs due to high intake of dense energy foods (carbohydrates) along with less physical activity which is required to burn the food [22]. Overweight is related to a number of comorbidities such as type 2 diabetes mellitus, cardiovascular diseases (stroke and heart) and certain cancers (breast, prostate, kidney, colon) [23]. There are various factors which affects our weight and to reduce or maintain weight one must have a healthy lifestyle, physical activity, reduce consumption of saturated fats, consume less sugars and salts and increase the intake of dietary vegetables and whole grains, as well as pharmacological therapies and surgical interventions [24]. Still obesity treatment is a challenging as only 5–10% of individuals are able to maintain their weight loss over years [25]. The weight loss is reversed when an individual abandons his/her healthy lifestyle or ceases pharmacotherapy [26]; also use of some synthetic drugs have side effects [27]. The pharmacological drugs can be replaced by herbal supplements which are not only efficient but also less expensive and most importantly safe.

3.2 Diabetes mellitus

Diabetes mellitus is a metabolic disorder and has increased rapidly in the past 20 years. Some medicinal plant species (Tarchonanthus camphoratus, Strychnos henningsii, Elaeodendron transvaalense, Euclea undulata, Hypoxis argentae, Schkuria pinnata and Cissampelo campensis) have the ability to increase glucose uptake in cultured cells such as hepatic cells, muscle cells and preadipocytes and thus, might show hypoglycemic activity by increasing peripheral glucose uptake [28]. Cucurbita pepo, Senna alexandri, Nuxia floribunda and Cymbopogon citrutus are some medicinal plants containing α-glucosidase and α-amylase inhibitors which might help in the reduction of post-prandial hyperglycemia [29]. H. argentae and Carica papaya are example of antidiabetic plants which has the ability to preserve and increase the regeneration of pancreatic β-cells resulting in increased insulin release [30]. In South Africa, diabetes treatment is done by some medicinal plants such as Hypoxis hemerocallidea, Catharanthus roseus, Vernonia amygdalina, Sutherlandia frutescens and Mimusops zeyheri. Although traditional practitioners have cited some medicinal plants showing antidiabetic properties, but still very few pharmacological data is available to confirm their efficiency. Also, the interaction of these medicinal plants with modern antidiabetic pharmacological drugs, its effective doses and toxicity levels are still unknown.

3.3 Cardiovascular disease (CVD)

CVD associated complications can be prevented by using anti-hypersensitive regimes to lower high blood pressure. Some traditionally used hyper-sensitive pharmaceutical drugs used are β-blockers, angiotensin receptor blockers, thiazide diuretics, calcium channel antagonists and vasodilators [31]. Several plant extracts have been identified possessing potential to treat CVDs including hypertension, congestive heart failure, ischemic heart disease and atherosclerosis [32].

For hypertension treatment, some healers of South Africa have used orally administered tincture of Helichrysum ceres. The hypotensive effect of the extract is due to the presence of diuretic and natriuretic bioactive phytochemical compounds [33]. In vivo studies have shown that H. ceres leaf ethanolic extract lowers blood pressure [34]. The extract acts on the vascular smooth muscles resulting in vasodilation which leads to total peripheral resistance (TPR) reduction. The ethanolic extract of Ekebergia capensis leaf prevents hypertension development in murine models. This hypotensive effect is due to the modulatory effect on TPR of vascular smooth muscles. Studies have shown that crude leaf extract of Opuntia megacantha can overturn the inability of kidney to excrete sodium in a streptozotocin-induced (STZ) diabetic rat model [35]. This indicates the beneficial effects of plant extracts in hypertension management by influencing the ability of kidney to regulate blood volume. Allium sativum (phenols and flavonoids) [36], Sclerocarya birrea (flavonoids and triterpenes) [37], Ficus thonningii (anthraquinones, flavonoids, and saponins) [38], and Olea europea (triterpenes, flavonoids, and glycosides) [39] are some medicinal plants used popularly in South Africa for hypertension management due to their cardioprotective, vasorelaxant and bradycardic effects. Isolated phytochemicals from wild African olive leaves (Olea europea) collected from Cape Town showed anti-hypersensitive, diuretic and anti-atherosclerotic effects [40]. When insulin-resistant rat model was treated with O. europea extracts for six-weeks, development of hypertension and atherosclerosis was prevented displaying its potential in hypertension management in Africans.

Renin-angiotensin-aldosterone system (RAAS) is a signalling pathway in blood pressure regulation which is targeted by the phytochemical constituents of medical plants showing anti-hypertensive property. During hypertension development, angiotensin I is converted to angiotensin II by an enzyme known as angiotensin-converting enzyme (ACE) and the enzymatic inhibition of ACE is analysed while screening for anti-hypertensive medicines [41]. In vitro studies have been done on South African medicinal plants to evaluate their inhibition potential against ACE. Ethanolic and aqueous extract of some medicinal plants have demonstrated inhibition activity against ACE, and they are Tulbaghia violacea, Amaranthus ybridus, Amaranthus dubius, Galinsoga parviflora, Stangeria eriopus, Oxygonum sinuatum, Physalis viscosa, Justicia flava and Oxygonum sinuatum. Among these medicinal plants, T. violacea exhibited highest activity [42]. The inhibition activity observed, is due to the presence of tannins in most of these plants as tannins interferes with the activity of ACE [43].

3.4 Non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is a major cause of morbidity and mortality. The disease is generally related with obesity, but recent studies show it can also develop independent of metabolic syndrome. Hoodia gordonii, a succulent plant was used as an appetite suppressant and due to its appetite-suppressing property, the succulent plant can be potentially used for NAFLD management. Recent studies have shown, Hoodia gordonii extracts have reduced the body mass of obese rats along with reduction in muscle mass and adipocyte size [44].

S. frutescens, a legume has various medicinal properties. It not only exhibits antidiabetic properties but recent studies have shown, it also has the ability to modify lipid metabolism in 3 T3 adipocytes as well as in insulin-resistant rats [45]. Studies have also shown, the aqueous extract of the plant can reverse fructose induced hepatic steatosis in vivo.

Aloe vera is well known for its medicinal properties against hepatic steatosis and it has also been demonstrated that its extract improves this condition in rats. Kaempferol is a bioactive compound in A. vera which exhibits hepatoprotective activity [46]. Lophenol and cycloartenol are some other A. vera phytosterols which when administered to Zucker diabetic fatty rats shows significant decrease of lipogenic gene expression and reduced hepatic lipid accumulation [47]. The mechanism of effectiveness of plant extracts in metabolic disorders is given in Table 2.

Metabolic disorderMedicinal plantMode of actionReferences
Diabetes mellitusTarchonanthus camphoratus, Strychnos henningsii, Elaeodendron transvaalense, Euclea undulata, Hypoxis argentae, Schkuria pinnata and Cissampelo campensis)Increase glucose uptakeOyedemi et al. [28]
Cucurbita pepo, Senna alexandri, Nuxia floribunda and Cymbopogon citrutusInhibit α-glucosidase and α-amylase and reduces hyperglycemiaBoaduo et al. [29]
H. argentae and Carica papayaregeneration of pancreatic β-cellsAkinrinde et al. [30]
Cardiovascular Disease (CVD)Helichrysum ceresLowers blood pressureMusabayane et al. [38]
Ekebergia capensisPrevents hypertensionKAMADyAAPA et al. [34]
Opuntia megacanthaInfluence kidney to regulate blood volumeBwititi et al. [35]
Allium sativum, Sclerocarya birrea, Ficus thonningii, and Olea europeaHypertension managementAl-Qattan et al. [36]; Braca et al. [37]; Musabayane et al. [38]; Bennani-Kabchi et al. [39]
Tulbaghia violaceaInhibition of angiotensin-converting enzyme (ACE)Ramesar et al. [42]
Non-alcoholic Fatty Liver DiseaseHoodia gordoniiSuppresses the appetiteSmith et al. [44]
S. frutescensModifies lipid metabolism in 3 T3 adipocytesMacKenzie et al. [45]
Aloe veraHepatoprotective activity, reduces lipid accumulationBhalla et al. [46]; Misawa et al. [47]

Table 2.

Mode of action of plant extracts against metabolic disorders.


4. Cancer

Cancer involves uncontrolled cell growth which can be initiated by various factors. Chemoprevention is a treatment makes use of natural, biological or synthetic agents to suppress, prevent or reverse carcinogenesis in its initial phase or prevent the invasion of premalignant cells [48]. Carcinogenesis occurs in three steps, initiation, promotion and progression. At molecular level, chemoprevention has been distinguished by altering these three pathways [49]. FDA has recently approved ten new agents for the treatment of precancerous lesions, reducing the risk of cancer [50]. Clinically, chemoprevention has be grouped as primary, secondary and tertiary. The primary chemoprevention is for people with no cancer, as well as for those who have the risk of developing cancer in future. The secondary chemoprevention is suitable for patients with pre-malignant lesions which in future may lead to invasive cancer. The tertiary prevention is to cure or prevent recurrence of cancer [49].

Capsaicin (trans-8-methyl-N-vanilly l-6-nonenamide), an active and pungent alkaloid found in Capsicum [51]. It has been reported that capsaicin has been used as an anticancer, tumour suppressing, chemopreventive and radio sensitising agent in various cancer models [52]. Capsaicin exhibited its ability to reduce pain and effective against osteoarthritis when applied topically [53]. It has been used as an alternative for oral non-steroidal anti-inflammatory drugs which had side effects. Capsaicin can be used as cancer treatment due to its properties such as carcinogens activity inhibition and inducing apoptosis in several cancer cell lines in vitro and in rodents [54].

Catechins are found in various beverages such as green tea [55]. These are naturally occurring dietary phytochemical and polyphenols. Very few studies have been reported showing association of cancer with consumption of dietary phytochemicals [56]. Major components of green tea are Catechin (C), epicatechin (EC), epigallocatechin (EGC) and epigallocatechin-3-gallate (EGCG) [57]. It has been reported that EGCG could enhance the activity of several anticancer drugs such as retinoids [58]. A synthetic retinoid, AM80, has been clinically used for relapsed and intractable acute promyelocytic leukaemia patients. A study demonstrated the use of AM80 and EGCG in combinations, induced apoptosis and upregulated the expression of inducible gene of damaged DNA including death receptor 5 (DR5), GADD153 and p21waf1 in lung cancer. The combination also showed downregulation of deacetylase 4, −5, and − 6, inducing apoptosis in lung cancer by Am80 and EGCG.

Lycopene is an antioxidant and thus shows protective effect against various diseases including cancer, hypertension, osteoporosis, cardiovascular diseases and neurodegenerative diseases [59]. Studies have been reported that lycopene accumulates in prostate tissue as compared to other tissues and this might be responsible for its anti-prostate cancer activity [60]. A study showed lycopene exhibits anti-angiogenic activity in in vitro as well as in vivo, suggesting the mechanism may involve modulation of PI3K-Akt and ERK/p38 signalling pathways [61]. Several studies have demonstrated use of lycopene and melatonin in combination showed strong chemopreventive activity through antioxidant and anti-inflammatory activities [62].

Isoflavones are isoflavonoids present in plants of leguminosae family [63]. It is extensively found in lentil, chickpeas, beans, soy and have importance in mammals as phytoestrogens. Isoflavones have several health benefits and are used for treating hormone-dependent medical conditions such cancer, cardiovascular disease, menopause and osteoporosis. Isoflavones extracted from soy, such as genistein, have been developed to have significant anticancer effects against as lymphoma, leukaemia, breast, prostate gastric and non-small cell lung cancer [64]. Studies have reported genistein showing anticancer effects in various cancer models such as breast cancer, lung cancer, ovarian cancer, prostate cancer, bladder cancer, renal cancer, cervical cancer, liver cancer, and head and neck squamous cell carcinoma [65].

Chemotherapy is an approach for cancer treatment but has several undesired side effects, including chemotherapy-induced peripheral neuropathy (CIPN) [66]. Recent studies have reviewed the preclinical and clinical studies on the efficiency of herbal medicines in CIPN. Cinnamon (Cinnamomum cassia (L.) D. Don), chamomile (Matricaria chamomilla L.), sage (Salvia officinalis L.), and sweet flag (Acorus calamus L.) are some medicinal plants, and curcumin, thioctic acid and matrine are some phytochemicals which have shown effective properties in CIPN animal models.


5. Oral health

Oral health reflects the physical and social well-being of an individual. The food consumed affects the oral health as they are naturally bioactive and is composed of minerals, vitamins and antioxidants [67]. Aromatic vegetables and spices used in it are not only appetising and savoury but also has therapeutic and preservative properties. Foods we consume have a number of benefits such as antibiotic, anti-inflammatory, anticarcinogenic and immunogenic properties. A study shows, vegetables (more than 440 g/day), fruits and spices rich diet can prevent 20% of all cancers [68]. According to a WHO report, there is 15% chance of suffering from oropharyngeal cancers due to dietary imbalance or deficiencies [69]. The people of Asia, USA and Europe suffer from oral squamous cell carcinoma due to low antioxidant and fibre intake. Many studies have proved that antioxidants and fibres exhibit chemotherapeutic and chemo-preventive properties.

In Mexico, various herbal therapies are used for the treatment of oral disorders such as mouth infection, teeth discoloration, gingivitis and periodontitis [70]. Even though, very less research has been performed demonstrating the antiplaque, antimicrobial and antibacterial effects of Mexican herbs, they can still me used for treating several periodontal diseases or as anticarcinogenic agent [70].


6. Wound healing

Wounds are injuries caused physically due to skin rupture which may lead to anatomical or functional disorders. Wound healing is a complex and dynamic process leading to reformation of tissue integrity and homeostasis [71]. The process involves inflammation, tissue formation, neovascularization, reepithelization, extracellular matrix remodelling and wound contraction. The process is coordinated by various signalling mechanism involving numerous growth factors, chemokines and cytokines. During the process, cell proliferation is necessary for tissue repair and its regeneration [72].

For more than 500 years, “Ayurveda” has been practiced in India to prevent and cure diseases. The process utilises plants for disease prevention and cure. Traditional Chinese medicine system has been in use all over eastern Asia for over 3000 years and it uses numerous medicinal plants [73]. Modern science has analysed the traditional medicinal plant species to identify bioactive constituents present in it and as many as 12 medicinal plants have undergone clinical trials with regard to their wound healing property.


7. Production

Plants immediately activate their defence mechanism when they are attacked. This also includes the biosynthesis of phytochemicals which occurs rapidly resulting in reduction of nutrients and amino acids. But the optimization of mass production of phytochemical is still unknown.

An efficient way for phytochemical production is creation of metabolic highways through protein complexes known as metabolons. Three decades ago, the existence of metabolons was first proposed. But it’s in vivo protein–protein interaction and structures are still challenging. Metabolons are involved in metabolic pathways, mostly primary and secondary including lignin, Krebs cycle and flavonoid pathways [74]. For the biosynthesis of toxic cyanogenic glucoside dhurrin which highly gets accumulated in sorghum, metabolons are essential (Sorghum bicolor) [75]. Metabolons can efficiently produce inducible phytochemicals. The biosynthesis efficiency can be increased by assembling the sequential enzymes of a pathway into a single protein complex and would also limit release of harmful or reactive intermediates. In these protein complexes, the phytochemical intermediates are released only when the metabolon is disassembled. Th 2019, Mucha et al. studied if a metabolon channels the biosynthesis of an essential defence metabolite in Arabidopsis (Arabidopsis thaliana), known as camalexin [76]. The biosynthesis of camalexin is an enzyme catalysed multi-step reaction and from tryptophan (Trp) various intermediates are generated which have been detected in knockout genotypes [77].

In vitro plant production is a solution which is favoured by biotechnologists. The in vitro technology allows to produce plants uniformly by controlled manipulation of environmental condition, growth regulators, and strategies that can enhance production as well as overall yield of phytochemicals. The naturally occurring instable chemical composition in plants can avoided by growing them on media prepared according to strict recipes for plant’s nutritional necessities under controlled environmental conditions including temperature, light duration and intensity [78].

The most efficient method for in vitro secondary metabolite production is plant micropropagation. This is a technique that uses clonal propagation to produce plants which are identical genetically as well as free from pathogens and contaminants, and this process requires very less space, time and supplies. A study demonstrated in vitro culture of tansy (Tanacetum vulgare) from seeds collected from natural population for production of secondary metabolites such as essential oils and methanol extracts [79]. Studies have reported, the use of plant growth regulators exogenously (auxin and cytokinin) might hinder genetical stability leading to somaclonal variation, which is undesirable for in vitro plant production when used for isolation of secondary metabolites [80].


8. Conclusion and future perspectives

The non- nutritive part of the plants that is, phytochemicals have antimetabolic, anti-cancer, anti-neurological and wound healing properties. They also help in maintaining oral health. The antimicrobial nature of phytochemicals has led to its increased demand. To meet the requirements of modern medicine, plants and their extracts are cultured in vitro. The use of huge bioreactors and mass propagation has led to the establishment of inexpensive and efficient method for phytochemical production. The regulation of in-vitro conditions to multiplication can be a promising technique for medicine.



The funding was provided by IntechOpen.


  1. 1. Makhuvele R, Naidu K, Gbashi S, Thipe VC, Adebo OA, Njobeh PB. The use of plant extracts and their phytochemicals for control of toxigenic fungi and mycotoxins. Heliyon. 2020 Oct 1;6(10):e05291.
  2. 2. Prakash B, Kumar A, Singh PP, Songachan LS. Antimicrobial and antioxidant properties of phytochemicals: Current status and future perspective. InFunctional and Preservative Properties of Phytochemicals 2020 Jan 1 (pp. 1-45). Academic Press.
  3. 3. Palombo EA. Traditional medicinal plant extracts and natural products with activity against oral bacteria: potential application in the prevention and treatment of oral diseases. Evidence-based complementary and Alternative Medicine. 2011 Jan 1;2011.
  4. 4. Alabi OA, Anokwuru CP, Ezekiel CN, Ajibaye O, Nwadike U, Fasasi O, Abu M. Anti-mutagenic and anti-genotoxic effect of ethanolic extract of neem on dietary aflatoxin induced genotoxicity in mice. J. Biol. Sci. 2011;11:307-317.
  5. 5. Das S, Chaudhari AK, Singh A, Singh VK, Dwivedy AK, Dubey NK. Foodborne microbial toxins and their inhibition by plant-based chemicals. InFunctional and Preservative Properties of Phytochemicals 2020 Jan 1 (pp. 165-207). Academic Press.
  6. 6. Bhattacharya S. Natural antimutagens: a review. Research Journal of Medicinal Plant. 2011;5(2):116-126.
  7. 7. Velu G, Palanichamy V, Rajan AP. Phytochemical and pharmacological importance of plant secondary metabolites in modern medicine. InBioorganic Phase in Natural Food: An Overview 2018 (pp. 135-156). Springer, Cham.
  8. 8. Reichling J, Schnitzler P, Suschke U, Saller R. Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties–an overview. Complementary Medicine Research. 2009;16(2):79-90.
  9. 9. Bergonzelli GE, Donnicola D, Porta N, Corthesy-Theulaz IE. Essential oils as components of a diet-based approach to management of Helicobacter infection. Antimicrobial agents and chemotherapy. 2003 Oct;47(10):3240.
  10. 10. Furneri PM, Paolino D, Saija A, Marino A, Bisignano G. In vitro antimycoplasmal activity of Melaleuca alternifolia essential oil. Journal of antimicrobial chemotherapy. 2006 Sep 1;58(3):706-707.
  11. 11. Inouye S, Yamaguchi H, Takizawa T. Screening of the antibacterial effects of a variety of essential oils on respiratory tract pathogens, using a modified dilution assay method. Journal of Infection and Chemotherapy. 2001 Jan 1;7(4):251-254.
  12. 12. Hammer KA, Carson CF, Riley TV. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. Journal of Antimicrobial Chemotherapy. 2004 Jun 1;53(6):1081-1085.
  13. 13. Dryden MS, Dailly S, Crouch M. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. Journal of Hospital Infection. 2004 Apr 1;56(4):283-286.
  14. 14. Jassim SA, Naji MA. Novel antiviral agents: a medicinal plant perspective. Journal of applied microbiology. 2003 Sep;95(3):412-427.
  15. 15. Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clinical microbiology reviews. 2003 Jan;16(1):114.
  16. 16. Schnitzler P, Koch C, Reichling J. Susceptibility of drug-resistant clinical herpes simplex virus type 1 strains to essential oils of ginger, thyme, hyssop, and sandalwood. Antimicrobial agents and chemotherapy. 2007 May;51(5):1859.
  17. 17. Asif M, Saleem M, Saadullah M, Yaseen HS, Al Zarzour R. COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties. Inflammopharmacology. 2020 Aug 14:1-9.
  18. 18. Dikhoba PM, Mongalo NI, Elgorashi EE, Makhafola TJ. Antifungal and anti-mycotoxigenic activity of selected South African medicinal plants species. Heliyon. 2019 Oct 1;5(10):e02668.
  19. 19. Abdel-Fattah SM, Badr AN, Ali SM, Hassan RA. Antifungal and anti-mycotoxigenic impact of eco-friendly extracts of wild stevia. Journal of Biological Sciences. 2018;18(8):488-499.
  20. 20. Gowda NK, Ledoux DR, Rottinghaus GE, Bermudez AJ, Chen YC. Efficacy of turmeric (Curcuma longa), containing a known level of curcumin, and a hydrated sodium calcium aluminosilicate to ameliorate the adverse effects of aflatoxin in broiler chicks. Poultry science. 2008 Jun 1;87(6):1125-1130.
  21. 21. Aydin S, Palabiyik ŞS, Erkekoglu P, Sahin G, Başaran N, Giray BK. The carotenoid lycopene protects rats against DNA damage induced by Ochratoxin A. Toxicon. 2013 Oct 1;73:96-103.
  22. 22. Kopelman PG. Obesity as a medical problem. Nature. 2000 Apr;404(6778):635-643.
  23. 23. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Archives of internal medicine. 2001 Jul 9;161(13):1581-1586.
  24. 24. McTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, Lohr KN. Screening and interventions for obesity in adults: summary of the evidence for the US Preventive Services Task Force. Annals of internal medicine. 2003 Dec 2;139(11):933-949.
  25. 25. Howard AN. The historical development, efficacy and safety of very-low-calorie diets. International journal of obesity. 1981 Jan 1;5(3):195-208.
  26. 26. Lowe MR. Self-regulation of energy intake in the prevention and treatment of obesity: is it feasible?. Obesity research. 2003 Oct;11(S10):44S-59S.
  27. 27. Abdollahi M, Afshar-Imani B. A review on obesity and weight loss measures. Middle East Pharmacy. 2003;11(5):6-10.
  28. 28. Oyedemi S, Koekemoer T, Bradley G, van de Venter M, Afolayan A. In vitro anti-hyperglycemia properties of the aqueous stem bark extract from Strychnos henningsii (Gilg). International Journal of Diabetes in Developing Countries. 2013 Jun 1;33(2):120-127.
  29. 29. Boaduo NK, Katerere D, Eloff JN, Naidoo V. Evaluation of six plant species used traditionally in the treatment and control of diabetes mellitus in South Africa using in vitro methods. Pharmaceutical biology. 2014 Jun 1;52(6):756-761.
  30. 30. Akinrinde A, Koekemoer T, Van De Venter M, Bradley G. In vitro investigation of potential anti-diabetic activity of the corm extract of Hypoxis argentea Harv. Ex Baker. Acta Pharmaceutica. 2018 Dec 31;68(4):389-407.
  31. 31. Nyakudya TT, Tshabalala T, Dangarembizi R, Erlwanger KH, Ndhlala AR. The potential therapeutic value of medicinal plants in the management of metabolic disorders. Molecules. 2020 Jan;25(11):2669.
  32. 32. Rastogi S, Pandey MM, Rawat AK. Traditional herbs: a remedy for cardiovascular disorders. Phytomedicine. 2016 Oct 15;23(11):1082-1089.
  33. 33. Musabayane CT. The effects of medicinal plants on renal function and blood pressure in diabetes mellitus. Cardiovascular journal of Africa. 2012 Sep;23(8):462.
  34. 34. KAMADyAAPA DR, Gondwe MM, Moodley K, Ojewole JA, MUSABAyANE CT. Cardiovascular effects of Ekebergia capensis Sparrm (Meliaceae) ethanolic leaf extract in experimental animal paradigms: cardiovascular topic. Cardiovascular journal of Africa. 2009 Jun 1;20(3):162-167.
  35. 35. Bwititi P, Musabayane CT, Nhachi CF. Effects of Opuntia megacantha on blood glucose and kidney function in streptozotocin diabetic rats. Journal of Ethnopharmacology. 2000 Mar 1;69(3):247-252.
  36. 36. Al-Qattan K, Thomson M, Ali M. Garlic (Allium sativum) and ginger (Zingiber officinale) attenuate structural nephropathy progression in streptozotocin-induced diabetic rats. e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism. 2008 Apr 1;3(2):e62-71.
  37. 37. Braca A, Politi M, Sanogo R, Sanou H, Morelli I, Pizza C, De Tommasi N. Chemical composition and antioxidant activity of phenolic compounds from wild and cultivated Sclerocarya birrea (Anacardiaceae) leaves. Journal of agricultural and food chemistry. 2003 Nov 5;51(23):6689-6695.
  38. 38. Musabayane CT, Gondwe M, Kamadyaapa DR, Chuturgoon AA, Ojewole JA. Effects of Ficus thonningii (Blume)[Morarceae] stem-bark ethanolic extract on blood glucose, cardiovascular and kidney functions of rats, and on kidney cell lines of the proximal (LLC-PK1) and distal tubules (MDBK). Renal failure. 2007 Jan 1;29(4):389-397.
  39. 39. Bennani-Kabchi N, Fdhil H, Cherrah Y, El Bouayadi F, Kehel L, Marquie G. Therapeutic effect of Olea europea var. oleaster leaves on carbohydrate and lipid metabolism in obese and prediabetic sand rats (Psammomys obesus). InAnnales pharmaceutiques francaises 2000 Jul 1 (Vol. 58, No. 4, pp. 271-277).
  40. 40. Somova LI, Shode FO, Ramnanan P, Nadar A. Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. Journal of ethnopharmacology. 2003 Feb 1;84(2-3):299-305.
  41. 41. Morgan TO, Anderson AI, MacInnis RJ. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. American journal of hypertension. 2001 Mar 1;14(3):241-247.
  42. 42. Ramesar S, Baijnath H, Govender T, Mackraj I. Angiotensin I-converting enzyme inhibitor activity of nutritive plants in KwaZulu-Natal. Journal of medicinal food. 2008 Jun 1;11(2):331-336.
  43. 43. Duncan AC, Jäger AK, van Staden J. Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. Journal of Ethnopharmacology. 1999 Dec 15;68(1-3):63-70.
  44. 44. Smith C, Krygsman A. Hoodia gordonii extract targets both adipose and muscle tissue to achieve weight loss in rats. Journal of ethnopharmacology. 2014 Sep 11;155(2):1284-1290.
  45. 45. MacKenzie J, Koekemoer TC, Roux S, van de Venter M, Dealtry GB. Effect of Sutherlandia frutescens on the lipid metabolism in an insulin resistant rat model and 3T3-L1 adipocytes. Phytotherapy Research. 2012 Dec;26(12):1830-1837.
  46. 46. Bhalla A, Chauhan UK. Identification of antihyperlipidemic components in Aloe vera through reverse phase HPlC. Journal of Biological Sciences and Medicine. 2015 Dec 31;1(1):21-27.
  47. 47. Misawa E, Tanaka M, Nabeshima K, Nomaguchi K, Yamada M, Toida T, Iwatsuki K. Administration of dried Aloe vera gel powder reduced body fat mass in diet-induced obesity (DIO) rats. Journal of nutritional science and vitaminology. 2012;58(3):195-201.
  48. 48. Sporn MB. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer research. 1976 Jul 1;36(7 Part 2):2699-702.
  49. 49. Pitot HC. The molecular biology of carcinogenesis. Cancer. 1993 Aug 1;72(S3):962-970.
  50. 50. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A. Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer. Cancer prevention research. 2010 Jun 1;3(6):696-706.
  51. 51. Pramanik KC, Fofaria NM, Gupta P, Ranjan A, Kim SH, Srivastava SK. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3. Oncotarget. 2015 May 10;6(13):11561.
  52. 52. Venier NA, Colquhoun AJ, Sasaki H, Kiss A, Sugar L, Adomat H, Fleshner NE, Klotz LH, Venkateswaran V. Capsaicin: A novel radio-sensitizing agent for prostate cancer. The Prostate. 2015 Feb;75(2):113-125.
  53. 53. Guedes V, Castro JP, Brito I. Topical capsaicin for pain in osteoarthritis: A literature review. Reumatología Clínica (English Edition). 2018 Jan 1;14(1):40-45.
  54. 54. Bley K, Boorman G, Mohammad B, McKenzie D, Babbar S. A comprehensive review of the carcinogenic and anticarcinogenic potential of capsaicin. Toxicologic pathology. 2012 Aug;40(6):847-873.
  55. 55. Prasanth MI, Sivamaruthi BS, Chaiyasut C, Tencomnao T. A review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy. Nutrients. 2019 Feb;11(2):474.
  56. 56. Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative medicine and cellular longevity. 2009 Nov 1;2(5):270-278.
  57. 57. Reygaert WC. Green tea catechins: Their use in treating and preventing infectious diseases. BioMed research international. 2018 Jul 17;2018.
  58. 58. Oya Y, Mondal A, Rawangkan A, Umsumarng S, Iida K, Watanabe T, Kanno M, Suzuki K, Li Z, Kagechika H, Shudo K. Down-regulation of histone deacetylase 4,− 5 and− 6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin. The Journal of nutritional biochemistry. 2017 Apr 1;42:7-16.
  59. 59. Rao AV, Ray MR, Rao LG. Lycopene. Advances in food and nutrition research. 2006 Jan 1;51:99-164.
  60. 60. Chen J, O’Donoghue A, Deng YF, Zhang B, Kent F, O’Hare T. The effect of lycopene on the PI3K/Akt signalling pathway in prostate cancer. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2014 Jul 1;14(6):800-5.Rao AV, Ray MR, Rao LG. Lycopene. Advances in food and nutrition research. 2006 Jan 1;51:99-164.
  61. 61. Chen ML, Lin YH, Yang CM, Hu ML. Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/u PA system through VEGFR 2-mediated PI 3 K-A kt and ERK/p38 signaling pathways. Molecular nutrition & food research. 2012 Jun;56(6):889-899.
  62. 62. Oguz E, Kocarslan S, Tabur S, Sezen H, Yilmaz Z, Aksoy N. Effects of lycopene alone or combined with melatonin on methotrexate-induced nephrotoxicity in rats. Asian Pacific journal of cancer prevention. 2015;16(14):6061-6066.
  63. 63. Wang Q, Ge X, Tian X, Zhang Y, Zhang J, Zhang P. Soy isoflavone: The multipurpose phytochemical. Biomedical reports. 2013 Sep 1;1(5):697-701.
  64. 64. Sarkar FH, Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer and Metastasis Reviews. 2002 Dec;21(3):265-280.
  65. 65. Ranjan A, Ramachandran S, Gupta N, Kaushik I, Wright S, Srivastava S, Das H, Srivastava S, Prasad S, Srivastava SK. Role of phytochemicals in cancer prevention. International journal of molecular sciences. 2019 Jan;20(20):4981.
  66. 66. Oveissi V, Ram M, Bahramsoltani R, Ebrahimi F, Rahimi R, Naseri R, Belwal T, Devkota HP, Abbasabadi Z, Farzaei MH. Medicinal plants and their isolated phytochemicals for the management of chemotherapy-induced neuropathy: therapeutic targets and clinical perspective. DARU Journal of Pharmaceutical Sciences. 2019 Jun;27(1):389-406.
  67. 67. Minaiyan M, Ghannadi A, Mahzouni P, Nabi-Meibodi M. Anti-ulcerogenic effect of ginger (rhizome of Zingiber officinale Roscoe) hydroalcoholic extract on acetic acid-induced acute colitis in rats. Research in pharmaceutical sciences. 2009 Nov 8;3(2):15-22.
  68. 68. Hsu S, Singh B, Schuster G. Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention. Oral Oncology. 2004 May 1;40(5):461-473.
  69. 69. Taghavi N, Yazdi I. Type of food and risk of oral cancer.
  70. 70. Cruz Martinez C, Diaz Gómez M, Oh MS. Use of traditional herbal medicine as an alternative in dental treatment in Mexican dentistry: a review. Pharmaceutical biology. 2017 Jan 1;55(1):1992-1998.
  71. 71. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. Journal of Investigative Dermatology. 2007 Mar 1;127(3):514-525.
  72. 72. Xing W, Guo W, Zou CH, Fu TT, Li XY, Zhu M, Qi JH, Song J, Dong CH, Li Z, Xiao Y. Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway. Journal of Dermatological Science. 2015 Aug 1;79(2):101-109.
  73. 73. Garodia P, Ichikawa H, Malani N, Sethi G, Aggarwal BB. From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol. 2007 Mar 21;5(1):25-37.
  74. 74. Bassard JE, Halkier BA. How to prove the existence of metabolons?. Phytochemistry Reviews. 2018 Apr;17(2):211-227.
  75. 75. Laursen T, Borch J, Knudsen C, Bavishi K, Torta F, Martens HJ, Silvestro D, Hatzakis NS, Wenk MR, Dafforn TR, Olsen CE. Characterization of a dynamic metabolon producing the defense compound dhurrin in sorghum. Science. 2016 Nov 18;354(6314):890-893.
  76. 76. Mucha S, Heinzlmeir S, Kriechbaumer V, Strickland B, Kirchhelle C, Choudhary M, Kowalski N, Eichmann R, Hückelhoven R, Grill E, Kuster B. The formation of a camalexin biosynthetic metabolon. The Plant Cell. 2019 Nov 1;31(11):2697-2710.
  77. 77. Böttcher C, Westphal L, Schmotz C, Prade E, Scheel D, Glawischnig E. The multifunctional enzyme CYP71B15 (PHYTOALEXIN DEFICIENT3) converts cysteine-indole-3-acetonitrile to camalexin in the indole-3-acetonitrile metabolic network of Arabidopsis thaliana. The Plant Cell. 2009 Jun 1;21(6):1830-1845.
  78. 78. Demetzos C, Angelopoulou D, Perdetzoglou D. A comparative study of the essential oils of Cistus salviifolius in several populations of Crete (Greece). Biochemical Systematics and Ecology. 2002 Jul 1;30(7):651-665.
  79. 79. Devrnja N, Anđelković B, Aranđelović S, Radulović S, Soković M, Krstić-Milošević D, Ristić M, Ćalić D. Comparative studies on the antimicrobial and cytotoxic activities of Tanacetum vulgare L. essential oil and methanol extracts. South African Journal of Botany. 2017 Jul 1;111:212-221.
  80. 80. Passinho-Soares HC, David JP, de Santana JR, David JM, de Rodrigues FM, Mesquita PR, de Oliveira FS, Bellintani MC. Influence of growth regulators on distribution of trichomes and the production of volatiles in micropropagated plants of Plectranthus ornatus. Revista Brasileira de Farmacognosia. 2017 Dec;27(6):679-680.

Written By

Aanchal Bansal and Chinmayee Priyadarsini

Submitted: 30 May 2021 Reviewed: 14 June 2021 Published: 15 July 2021